title: Cellular and reticular variants of haemangioblastoma revisited: a clinicopathologic study of 88 cases.
abstract: The presence of histological variants of haemangioblastoma is well established, but data on the prognostic implications of histological subtyping are missing. We thus characterized clinical factors associated with histological subtypes, that is, of the cellular and reticular variant of haemangioblastoma, in a series of 88 consecutive primary haemangioblastomas of the central nervous system. Ten haemangioblastomas were classified as 'cellular' according to Cushing and Bailey. As compared to the more common 'reticular' variant (n = 78), the proportion of tumours containing glial fibrillary acidic protein-positive tumour cells (80% vs. 7%), as well as median Ki67 (MIB1) proliferation indices [4% (quartiles: 1-8%) vs. < 1% (<1-2%)], was significantly higher in cellular haemangioblastomas (P < 0.01). Recurrences were more frequent in the cellular variant [2/8 (25%) vs. 4/51 (8%)]. Kaplan-Meier analysis confirmed a significantly higher probability of recurrence in the cellular variant (Log-Rank test P < 0.01). Cox regression analysis not only confirmed the well established association of von Hippel-Lindau disease with tumour recurrence (P < 0.01), but also revealed an independent effect of histological subtype on the probability of recurrence (P < 0.05), whereas no significant influence of age, sex or tumour location was observed. To conclude, the results from this retrospective study suggest that histological subtyping of haemangioblastomas has prognostic implications and might contribute to identify patients at risk for recurrence.
authors.affiliation: Institute of Neuropathology, University Hospital Münster, Germany. hasselblatt@uni-muenster.de
authors.forename: M
authors.initials: M
authors.lastname: Hasselblatt
authors.forename: A
authors.initials: A
authors.lastname: Jeibmann
authors.forename: J
authors.initials: J
authors.lastname: Gerss
authors.forename: C
authors.initials: C
authors.lastname: Behrens
authors.forename: B
authors.initials: B
authors.lastname: Rama
authors.forename: H
authors.initials: H
authors.lastname: Wassmann
authors.forename: W
authors.initials: W
authors.lastname: Paulus
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002528:Cerebellar Neoplasms / Q000453:epidemiology / Q000473:pathology*; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D018325:Hemangioblastoma / Q000453:epidemiology / Q000473:pathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology / Q000473:pathology*; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D013125:Spinal Neoplasms / Q000453:epidemiology / Q000473:pathology*